Member Area

Farmavita.Net - Pharmaceutical Licensing Network

Sunday
Dec 21st
Home arrow Farmavita.Net Journal arrow Life Science Files arrow Matrix Drug Delivery System
Matrix Drug Delivery System Print E-mail
Life Sciences - Life Science Article
Written by Debjit Bhowmik   
Monday, 27 July 2009

medicine_by_momoc.jpg

RECENT TRENDS IN SUSTAINED RELEASE MATRIX DRUG DELIVERY SYSTEM-AN OVERVIEW

Oral drug delivery has been known for decades as the most widely utilized route of administration among all the routes that have been employed for the systemic delivery of drug via various pharmaceutical products of different dosage forms. The reasons that the oral route achieved such popularity may be in part attributed to its ease of administration belief that by oral administration of the drug is well absorbed.

The whole 21 pages article is available for download at Downloads section of Farmavita.Net

All the pharmaceutical products formulated for systemic delivery via the oral route of administration irrespective of the mode of delivery (immediate, sustained or controlled release) and the design of dosage forms (either solid dispersion or liquid) must be developed within the intrinsic characteristics of GI physiology, pharmacokinetics, pharmacodynamics and formulation design is essential to achieve a systemic approach to the successful development of an oral pharmaceutical dosage form. Sustained release system includes any delivery system that achieves release of drug over an extended period of time. If the system at maintaining constant drug level in the blood of target time, it is considered a controlled release system. If it is unsuccessful at this but nevertheless extends the duration of action over that achieved by conventional delivery, it is considered a prolonged release system.

RATIONALE OF SUSTAINED AND CONTROLLED DRUG DELIVERY

The basic rationale for sustained and controlled drug delivery is to alter the pharmacokinetics and pharmacodynamics of pharmacological active moieties by using novel drug delivery system or by modifying the molecular structure and physiological parameters inherent in the selected route of administration. It is desirable that the duration of drug action becomes more a design property of a rate controlled dosage form and less or not at all a property of the drug molecules inherent kinetics properties. Thus optional design of controlled release systems necessitates a thorough understanding of the pharmacokinetics and pharmacodynamics of the drugs2.

SUSTAINED DRUG DELIVERY SYSTEM

Over the past 30 years, as the expense and complication involved in marketing new entities have increased with concomitant recognition of the therapeutical advantages of controlled drug delivery, greater attention has been focused on development of sustained or controlled drug delivery system. Sustained release technology is relatively new field and as a consequence, research in the field has been extremely fertile and has produced many discoveries. With many drugs, the basic goal is to achieve a steady state blood level that is therapeutically effective and non-toxic for an extended period of time. The design of proper dosage form is an important element to accomplish this goal. Sustained release, sustained action, prolonged action, controlled release, extended action, timed release and depot dosage form are term used to identify drug delivery system that are designed to achieve prolonged therapeutic effect by continuously releasing medication over an extended period of time after admininisatration of a single dose. In the case of oral sustained released dosage form, an effect is for several hours depending upon residence time of formulation in the GIT.

Physician can achieve several desirable therapeutics advantages by prescribing sustained release dosage form. Since, the frequency of drug administration is reduced, patient's compliances can be improved and the drug administration can be made more convenient as well. The blood level oscillation characteristics of multiple dosing form of conventional dosage form is reduced, because more even blood level is maintained in the design of sustained release dosage form. The total amount of drug administered, thus maximum availability with a minimum dose. In addition, the safety margin of high potency drug can be increased and the incidence of both local and systemic adverse effects can be reduced in sensitive patients. Overall, increased administration of sustained release dosage form gives increased reliability.

The whole 21 pages article is available for download at Downloads section of Farmavita.Net 

Comments
Search RSS
Tabssum Ashish Mullani  - I want full article   |2013-04-21 13:22:10
Its nice article.
Only registered users can write comments!

3.26 Copyright (C) 2008 Compojoom.com / Copyright (C) 2007 Alain Georgette / Copyright (C) 2006 Frantisek Hliva. All rights reserved."

Read also at Pharmaceutical Licensing Network
Newer news items
Related Items
Farmavita.Net - The Pharmaceutical Licensing Network




Reddit!Del.icio.us!Google!Live!Facebook!Slashdot!Netscape!Technorati!StumbleUpon!Newsvine!Furl!Blogmarks!Yahoo!Ma.gnolia!FeedMeLinks!Free social bookmarking plugins and extensions for Joomla! websites!
 
< Prev   Next >
Advertisement
  • Networking Tips & Tricks

    Monitoring news at Farmavita.Net

    You can easily monitor all new articles published  at Farmavita.Net . Click on the RSS button and bookmark the main  RSS feed of Farmavita.Net.  RSS button is located in URL field of your browser and also at the lower right side of every Farmavita.Net page

     
  • Latest Published
 

Featured Partners

 medcommeu15_150x150.gif  
meddevma14_150x150.gif  
2015-pmr-banner-150x150.gif  
barcelona2015_150x150_v2.gif 
150x150.jpg 
p-126-150x150.jpg 
p-128-150x150.jpg  
inls05_150x150.jpg 
meddevproc15_150x150.gif 
medaff15a_150x150.gif 

Follow us on:




Join our LinkedIn Group

BabelFish Translator




Click Flag for Translation

Who's Online

We have 26 guests online

Farmavita.Net RSS News


Reports

rbdl0002_innovations-in-inj.gif 

Events

2015-pmr-canada-banner-150x150.gif

Reports

rbhc0264_privatehealthcare.gif 

REPORTS

farmavita_research-store.gif